since there are few available data on the effect of ketanserin , a new antihypertensive drug which is a type-2 serotonin receptor antagonist , on human respiratory function , we have tested whether this drug can modify bronchial hyperresponsiveness to methacholine in asthmatic patients .
C0085129
bronchial
C0600370
methacholine